Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1976 Jun 15;156(3):539–543. doi: 10.1042/bj1560539

The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by triton WR-1339.

J Borensztajn, M S Rone, T J Kotlar
PMCID: PMC1163786  PMID: 949335

Abstract

1. Lipoprotein lipase activity was measured in heart homogenates and in heparin-releasable and non-releasable fractions of isolated perfused rat hearts, after the intravenous injection of Triton WR-1339. 2. In homogenates of hearts from starved, rats, lipoprotein lipase activity was significantly inhibited (P less than 0.001) 2h after the injection of Triton. This inhibition was restricted exclusively to the heparin-releasable fraction. Maximum inhibition occurred 30 min after the injection and corresponded to about 60% of the lipoprotein lipase activity that could be released from the heart during 30 s perfusion with heparin. 3. Hearts of Triton-treated starved rats were unable to take up and utilize 14C-labelled chylomicron triacylglycerol fatty acids, even though about 40% of heparin-releasable activity remained in the hearts. 4. It is concluded that Triton selectively inhibits the functional lipoprotein lipase, i.e. the enzyme directly involved in the hydrolysis of circulating plasma triacylglycerols. 5. Lipoprotein lipase activities measured in homogenates of soleus muscle of starved rats and adipose tissue of fed rats were decreased by 25 and 39% respectively after Triton injection. It is concluded that, by analogy with the heart, these Triton-inhibitable activities correspond to the functional lipoprotein lipase.

Full text

PDF
539

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanchette-Mackie E. J., Scow R. O. Sites of lipoprotein lipase activity in adipose tissue perfused with chylomicrons. Electron microscope cytochemical study. J Cell Biol. 1971 Oct;51(1):1–25. doi: 10.1083/jcb.51.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borensztajn J., Robinson D. S. The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart. J Lipid Res. 1970 Mar;11(2):111–117. [PubMed] [Google Scholar]
  3. Borensztajn J., Rone M. S., Sandros T. Effects of colchicine and cycloheximide on the functional and non-functional lipoprotein lipase fractions of rat heart. Biochim Biophys Acta. 1975 Sep 19;398(3):394–400. doi: 10.1016/0005-2760(75)90190-3. [DOI] [PubMed] [Google Scholar]
  4. Borensztajn J., Samols D. R., Rubenstein A. H. Effects of insulin on lipoprotein lipase activity in the rat heart and adipose tissue. Am J Physiol. 1972 Dec;223(6):1271–1275. doi: 10.1152/ajplegacy.1972.223.6.1271. [DOI] [PubMed] [Google Scholar]
  5. Chajek T., Stein O., Stein Y. Interference with the transport of heparin-releasable lipoprotein lipase in the perfused rat heart by colchicine and vinblastine. Biochim Biophys Acta. 1975 May 22;388(2):260–268. doi: 10.1016/0005-2760(75)90131-9. [DOI] [PubMed] [Google Scholar]
  6. Cunningham V. J., Robinson D. S. Clearing-factor lipase in adipose tissue. Distinction of different states of the enzyme and the possible role of the fat cell in the maintenance of tissue activity. Biochem J. 1969 Apr;112(2):203–209. doi: 10.1042/bj1120203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Enser M. B., Kunz F., Borensztajn J., Opie L. H., Robinson D. S. Metabolism of triglyceride fatty acid by the perfused rat heart. Biochem J. 1967 Jul;104(1):306–317. doi: 10.1042/bj1040306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FRIEDMAN M., BYERS S. O. The mechanism responsible for the hypercholesteremia induced by triton WR-1339. J Exp Med. 1953 Jan;97(1):117–130. doi: 10.1084/jem.97.1.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Otway S., Robinson D. S. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol. 1967 May;190(2):321–332. doi: 10.1113/jphysiol.1967.sp008211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SCANU A., ORIENTE P., SZAJEWSKI J. M., McCORMACK L. J., PAGE I. H. Triton hyperlipemia in dogs. II. Atheroscieross, diffuse lipidosis, and deletion of fat stores produced by prolonged administration of the non-tonic surface-active agent. J Exp Med. 1961 Sep 1;114:279–294. doi: 10.1084/jem.114.3.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SCANU A., ORIENTE P. Triton hyperlipemia in dogs. I. In vitro effects of the detergent on serum lipoproteins and chylomcrons. J Exp Med. 1961 Apr 1;113:735–757. doi: 10.1084/jem.113.4.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. SCHOTZ M. C., SCANU A., PAGE I. H. Effect of triton on lipoprotein lipase of rat plasma. Am J Physiol. 1957 Feb;188(2):399–402. doi: 10.1152/ajplegacy.1957.188.2.399. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES